Signaling Flux Redistribution in TLR4 Pathway
Author Information
Author(s): Selvarajoo Kumar, Takada Yasunari, Gohda Jin, Helmy Mohamed, Akira Shizuo, Tomita Masaru, Tsuchiya Masa, Inoue Jun-ichiro, Matsuo Koichi
Primary Institution: Institute for Advanced Biosciences, Keio University
Hypothesis
How do gain or loss-of-function mutations of MyD88 affect the TLR4 signaling pathways?
Conclusion
The study demonstrates that the removal of MyD88 enhances the TRAM-dependent pathway through a novel mechanism called signaling flux redistribution.
Supporting Evidence
- Removal of MyD88 enhances TRAM-dependent pathway activation.
- Increased IRF3 phosphorylation was observed in MyD88-deficient macrophages.
- Computational models predicted enhanced TRAM activation in MyD88 KO conditions.
- Experimental results confirmed the predictions of the computational model.
- TRAM and MyD88 compete for binding to TLR4.
Takeaway
When certain molecules are removed from a signaling pathway, other pathways can become stronger, like how removing MyD88 makes another pathway work better.
Methodology
The study used a computational model combined with in vivo and in vitro experiments to analyze TLR4 signaling pathways.
Limitations
The model may not account for all biological complexities and interactions in vivo.
Participant Demographics
Nine-week-old MyD88-deficient and wildtype mice were used.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website